Delivery Order SPE2DB20D2014-SPE2DB26FA20V
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,569.17 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,156.03 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of May 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,322.26 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on May 27, 2025. This competitively awarded, firm fixed-price delivery order is structured with an ultimate completion date of May 28, 2025, and carries no set-aside designation. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human...
- The Defense Logistics Agency awarded a delivery order valued at $7,313.71 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections. This competitively awarded, firm fixed price contract with no set-aside designation is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal medical supply...
- The Defense Logistics Agency awarded a $5,286.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $9,361.19 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on July 16, 2025, with an ultimate completion date of July 17, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This transaction...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Teriparatide 560 mcg/2.24 mL pen injections, with a contract ceiling value of $3,207.64 and a completion date of October 29, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, valued at $56,123.17. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for completion by October 28, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24mL pens valued at $6,554.84 with a firm fixed price structure. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a $4,168.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Teriparatide 560mcg/2.24ml pens. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The award is non-set-aside and was competitively awarded. Performance will be completed by July 25,...